Lipella Pharmaceuticals Inc. (LIPO) SEC filings

LIPO SEC filings moved a median of -0.67% by the close. LIPO SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the LIPO overview →

70 measured LIPO SEC filing events.

Where these LIPO SEC filings landedvs 70 measured LIPO SEC filing reactions
LIPO SEC filingMiddle 50% · -5.47% to +3.21%Zero: 0.00%Median: -0.67%Median -0.67%-8.00%0+8.00%
Middle 50% of LIPO SEC filing reactions-5.47% to +3.21%
Median reaction (to close)-0.67%
Measured reactions70
Point-in-time · zero look-ahead

Half of the 70 LIPO SEC filing events with a measured close landed between -5.47% and +3.21%; 44% closed up.

DateHeadlineEvent5-minTo close
Form 8-K LIPELLA PHARMACEUTICALS For: Jun 12SEC filing · Form 8-K—-7.71%
Form 8-K LIPELLA PHARMACEUTICALS For: Mar 30SEC filing · Form 8-K+10.00%+15.88%
Form 8-K LIPELLA PHARMACEUTICALS For: Feb 03SEC filing · Form 8-K+0.00%-10.34%
Form 10-Q LIPELLA PHARMACEUTICALS For: Sep 30SEC filing · Form 10-Q+0.00%-8.12%
Form 8-K LIPELLA PHARMACEUTICALS For: Oct 20SEC filing · Form 8-K+0.00%+0.00%
Form 8-K LIPELLA PHARMACEUTICALS For: Oct 03SEC filing · Form 8-K+0.00%-8.64%
Form 8-K LIPELLA PHARMACEUTICALS For: Sep 18SEC filing · Form 8-K-6.34%-0.09%
Form 10-Q LIPELLA PHARMACEUTICALS For: Jun 30SEC filing · Form 10-Q+0.00%-1.52%
Form 8-K LIPELLA PHARMACEUTICALS For: Jun 25SEC filing · Form 8-K+7.10%+24.44%
Form 8-K LIPELLA PHARMACEUTICALS For: Jun 20SEC filing · Form 8-K-6.06%-33.33%
Form 8-K LIPELLA PHARMACEUTICALS For: Jun 16SEC filing · Form 8-K+0.00%-6.08%
Form PRE 14A LIPELLA PHARMACEUTICALS For: Jul 21SEC filing · Form PRE+0.00%-4.44%
Form 8-K LIPELLA PHARMACEUTICALS For: May 16SEC filing · Form 8-K-2.35%+10.26%
Form 8-K LIPELLA PHARMACEUTICALS For: May 15SEC filing · Form 8-K+1.27%-5.51%
Form 10-Q LIPELLA PHARMACEUTICALS For: Mar 31SEC filing · Form 10-Q+1.27%-5.51%
Form 8-K LIPELLA PHARMACEUTICALS For: Apr 14SEC filing · Form 8-K—-0.41%
Form 8-K LIPELLA PHARMACEUTICALS For: Apr 09SEC filing · Form 8-K—+9.59%
Form 8-K LIPELLA PHARMACEUTICALS For: Apr 07SEC filing · Form 8-K+0.00%+6.91%
Form EFFECT LIPELLA PHARMACEUTICALSSEC filing · Form EFFECT-0.92%-2.98%
Form D LIPELLA PHARMACEUTICALSSEC filing · Form D+0.41%+4.90%
Form 10-K LIPELLA PHARMACEUTICALS For: Dec 31SEC filing · Form 10-K—+0.39%
Form S-3 LIPELLA PHARMACEUTICALSSEC filing · Form S-3—+0.39%
Form 8-K LIPELLA PHARMACEUTICALS For: Mar 18SEC filing · Form 8-K-0.89%+5.36%
Form 8-K LIPELLA PHARMACEUTICALS For: Mar 11SEC filing · Form 8-K-1.41%+5.63%
Form 8-K LIPELLA PHARMACEUTICALS For: Mar 03SEC filing · Form 8-K+0.00%-8.06%
Form 8-K LIPELLA PHARMACEUTICALS For: Feb 24SEC filing · Form 8-K-0.83%+6.46%
Form 8-K LIPELLA PHARMACEUTICALS For: Feb 11SEC filing · Form 8-K-4.19%-6.70%
Form EFFECT LIPELLA PHARMACEUTICALSSEC filing · Form EFFECT—-2.34%
Form 8-K LIPELLA PHARMACEUTICALS For: Jan 10SEC filing · Form 8-K-2.03%+4.83%
Form D LIPELLA PHARMACEUTICALSSEC filing · Form D+4.17%+1.60%
Form S-3 LIPELLA PHARMACEUTICALSSEC filing · Form S-3+4.17%+1.60%
Form 8-K LIPELLA PHARMACEUTICALS For: Dec 31SEC filing · Form 8-K-2.24%-10.92%
Form 8-K LIPELLA PHARMACEUTICALS For: Dec 30SEC filing · Form 8-K-1.60%-2.24%
Form 8-K LIPELLA PHARMACEUTICALS For: Dec 27SEC filing · Form 8-K-2.02%-3.41%
Form 8-K LIPELLA PHARMACEUTICALS For: Dec 20SEC filing · Form 8-K—+17.88%
Form DEFA14A LIPELLA PHARMACEUTICALSSEC filing · Form DEFA14A—+17.88%
Form 8-K LIPELLA PHARMACEUTICALS For: Dec 05SEC filing · Form 8-K—+0.00%
Form 8-K LIPELLA PHARMACEUTICALS For: Dec 06SEC filing · Form 8-K+3.45%+4.48%
Form DEFA14A LIPELLA PHARMACEUTICALSSEC filing · Form DEFA14A+3.45%+4.48%
Form 10-Q LIPELLA PHARMACEUTICALS For: Sep 30SEC filing · Form 10-Q+0.00%-3.69%
Form DEF 14A LIPELLA PHARMACEUTICALS For: Dec 06SEC filing · Form DEF-0.00%-1.67%
Form 8-K LIPELLA PHARMACEUTICALS For: Nov 07SEC filing · Form 8-K+1.82%+17.50%
Form 8-K LIPELLA PHARMACEUTICALS For: Nov 01SEC filing · Form 8-K-2.08%-12.97%
Form PRE 14A LIPELLA PHARMACEUTICALS For: Dec 06SEC filing · Form PRE-2.08%-12.97%
Form 8-K LIPELLA PHARMACEUTICALS For: Oct 18SEC filing · Form 8-K-3.13%+2.00%
Form 8-K LIPELLA PHARMACEUTICALS For: Sep 11SEC filing · Form 8-K+0.51%-3.15%
Form 8-K LIPELLA PHARMACEUTICALS For: Aug 23SEC filing · Form 8-K-4.42%-10.79%
Form D LIPELLA PHARMACEUTICALSSEC filing · Form D—-3.78%
Form 10-Q LIPELLA PHARMACEUTICALS For: Jun 30SEC filing · Form 10-Q+0.00%-0.93%
Form ARS LIPELLA PHARMACEUTICALS For: Dec 31SEC filing · Form ARS-2.00%-5.35%
Form DEF 14A LIPELLA PHARMACEUTICALS For: Sep 10SEC filing · Form DEF-2.00%-5.35%
Form 8-K LIPELLA PHARMACEUTICALS For: Aug 06SEC filing · Form 8-K-2.92%-5.17%
Form 8-K LIPELLA PHARMACEUTICALS For: Aug 01SEC filing · Form 8-K+0.00%-6.38%
Form PRE 14A LIPELLA PHARMACEUTICALS For: Jul 30SEC filing · Form PRE+3.15%+1.93%
Form 10-Q LIPELLA PHARMACEUTICALS For: Mar 31SEC filing · Form 10-Q—-3.67%
Form 8-K LIPELLA PHARMACEUTICALS For: Apr 19SEC filing · Form 8-K—+0.70%
Form 8-K LIPELLA PHARMACEUTICALS For: Apr 12SEC filing · Form 8-K+6.20%+7.15%
Form 8-K LIPELLA PHARMACEUTICALS For: Mar 15SEC filing · Form 8-K-0.33%+1.27%
Form S-8 LIPELLA PHARMACEUTICALSSEC filing · Form S-8—+3.38%
Form 10-K LIPELLA PHARMACEUTICALS For: Dec 31SEC filing · Form 10-K-0.48%-0.96%
Form EFFECT LIPELLA PHARMACEUTICALSSEC filing · Form EFFECT—+1.22%
Form S-3 LIPELLA PHARMACEUTICALSSEC filing · Form S-3-5.40%+1.94%
Form 8-K LIPELLA PHARMACEUTICALS For: Dec 01SEC filing · Form 8-K—+0.88%
Form 8-K LIPELLA PHARMACEUTICALS For: Nov 28SEC filing · Form 8-K—+0.42%
Form 8-K LIPELLA PHARMACEUTICALS For: Nov 22SEC filing · Form 8-K—-0.93%
Form 10-Q LIPELLA PHARMACEUTICALS For: Sep 30SEC filing · Form 10-Q+0.89%+2.68%
Form EFFECT LIPELLA PHARMACEUTICALSSEC filing · Form EFFECT—+6.95%
Form D LIPELLA PHARMACEUTICALSSEC filing · Form D+0.00%-7.56%
Form S-1 LIPELLA PHARMACEUTICALSSEC filing · Form S-1-14.29%-8.73%
Form 8-K LIPELLA PHARMACEUTICALS For: Oct 23SEC filing · Form 8-K-8.55%-28.13%
That’s how LIPO usually reacts to SEC filings — get an email when it moves on news →
Keep exploring

More LIPO: earnings → · analyst actions → · LIPO overview →